155 related articles for article (PubMed ID: 16774988)
1. Intracellular angiotensin II induces cell proliferation independent of AT1 receptor.
Baker KM; Kumar R
Am J Physiol Cell Physiol; 2006 Nov; 291(5):C995-1001. PubMed ID: 16774988
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta receptor endoglin is expressed in cardiac fibroblasts and modulates profibrogenic actions of angiotensin II.
Chen K; Mehta JL; Li D; Joseph L; Joseph J
Circ Res; 2004 Dec; 95(12):1167-73. PubMed ID: 15539634
[TBL] [Abstract][Full Text] [Related]
3. Ligand binding and functional properties of human angiotensin AT1 receptors in transiently and stably expressed CHO-K1 cells.
Le MT; De Backer JP; Hunyady L; Vanderheyden PM; Vauquelin G
Eur J Pharmacol; 2005 Apr; 513(1-2):35-45. PubMed ID: 15878707
[TBL] [Abstract][Full Text] [Related]
4. The effects of different angiotensin II type 1 receptor blockers on the regulation of the ACE-AngII-AT1 and ACE2-Ang(1-7)-Mas axes in pressure overload-induced cardiac remodeling in male mice.
Wang X; Ye Y; Gong H; Wu J; Yuan J; Wang S; Yin P; Ding Z; Kang L; Jiang Q; Zhang W; Li Y; Ge J; Zou Y
J Mol Cell Cardiol; 2016 Aug; 97():180-90. PubMed ID: 27210827
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the partially insurmountable antagonist valsartan and human recombinant angiotensin II type 1 receptors.
Verheijen I; Fierens FL; Debacker JP; Vauquelin G; Vanderheyden PM
Fundam Clin Pharmacol; 2000; 14(6):577-85. PubMed ID: 11206708
[TBL] [Abstract][Full Text] [Related]
6. Sarcosine1, glycine8 angiotensin II is a functional AT1 angiotensin receptor antagonist.
Speth RC; Kim KH; Elton TS; Simasko S
Endocrine; 2005 Mar; 26(2):83-7. PubMed ID: 15888919
[TBL] [Abstract][Full Text] [Related]
7. Internalization of constitutively active N111G MUTANT of AT1 receptor induced by angiotensin II-receptor antagonists candesartan, losartan, and telmisartan: comparison with valsartan.
Bhuiyan MA; Hossain M; Nakamura T; Ozaki M; Nagatomo T
J Pharmacol Sci; 2010; 112(4):459-62. PubMed ID: 20308802
[TBL] [Abstract][Full Text] [Related]
8. Distinction between surmountable and insurmountable selective AT1 receptor antagonists by use of CHO-K1 cells expressing human angiotensin II AT1 receptors.
Vanderheyden PM; Fierens FL; De Backer JP; Fraeyman N; Vauquelin G
Br J Pharmacol; 1999 Feb; 126(4):1057-65. PubMed ID: 10193788
[TBL] [Abstract][Full Text] [Related]
9. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist.
Lochard N; Thibault G; Silversides DW; Touyz RM; Reudelhuber TL
Circ Res; 2004 Jun; 94(11):1451-7. PubMed ID: 15117826
[TBL] [Abstract][Full Text] [Related]
10. Molecular characterisation of the interactions between olmesartan and telmisartan and the human angiotensin II AT1 receptor.
Le MT; Pugsley MK; Vauquelin G; Van Liefde I
Br J Pharmacol; 2007 Aug; 151(7):952-62. PubMed ID: 17572702
[TBL] [Abstract][Full Text] [Related]
11. Intracellular angiotensin II fusion protein alters AT1 receptor fusion protein distribution and activates CREB.
Cook JL; Re R; Alam J; Hart M; Zhang Z
J Mol Cell Cardiol; 2004 Jan; 36(1):75-90. PubMed ID: 14734050
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of facilitation of sympathetic neurotransmission and angiotensin II-induced pressor effects in the pithed rat: comparison between valsartan, candesartan, eprosartan and embusartan.
Balt JC; Mathy MJ; Pfaffendorf M; van Zwieten PA
J Hypertens; 2001 Dec; 19(12):2241-50. PubMed ID: 11725169
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II (AT(1)) receptor blockade reduces vascular tissue factor in angiotensin II-induced cardiac vasculopathy.
Müller DN; Mervaala EM; Dechend R; Fiebeler A; Park JK; Schmidt F; Theuer J; Breu V; Mackman N; Luther T; Schneider W; Gulba D; Ganten D; Haller H; Luft FC
Am J Pathol; 2000 Jul; 157(1):111-22. PubMed ID: 10880382
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptor blockade in normotensive subjects: A direct comparison of three AT1 receptor antagonists.
Mazzolai L; Maillard M; Rossat J; Nussberger J; Brunner HR; Burnier M
Hypertension; 1999 Mar; 33(3):850-5. PubMed ID: 10082498
[TBL] [Abstract][Full Text] [Related]
15. Valsartan and telmisartan abrogate angiotensin II-induced downregulation of ABCA1 expression via AT1 receptor, rather than AT2 receptor or PPARγ activation.
Chen HY; Xu Z; Chen LF; Wang W; Fang Q; Yan XW
J Cardiovasc Pharmacol; 2012 Jun; 59(6):570-5. PubMed ID: 22392065
[TBL] [Abstract][Full Text] [Related]
16. Effects of valsartan on angiotensin II-induced migration of human coronary artery smooth muscle cells.
Kohno M; Ohmori K; Nozaki S; Mizushige K; Yasunari K; Kano H; Minami M; Yoshikawa J
Hypertens Res; 2000 Nov; 23(6):677-81. PubMed ID: 11131281
[TBL] [Abstract][Full Text] [Related]
17. AT(1) receptor blockers increase insulin-like growth factor-I production by stimulating sensory neurons in spontaneously hypertensive rats.
Harada N; Shimozawa N; Okajima K
Transl Res; 2009 Sep; 154(3):142-52. PubMed ID: 19665690
[TBL] [Abstract][Full Text] [Related]
18. Binding of the antagonist [3H]candesartan to angiotensin II AT1 receptor-transfected [correction of tranfected] Chinese hamster ovary cells.
Fierens F; Vanderheyden PM; De Backer JP; Vauquelin G
Eur J Pharmacol; 1999 Feb; 367(2-3):413-22. PubMed ID: 10079018
[TBL] [Abstract][Full Text] [Related]
19. Renal nitric oxide production is decreased in diabetic rats and improved by AT1 receptor blockade.
Awad AS; Webb RL; Carey RM; Siragy HM
J Hypertens; 2004 Aug; 22(8):1571-7. PubMed ID: 15257181
[TBL] [Abstract][Full Text] [Related]
20. Effect of saponin and filipin on antagonist binding to AT 1 receptors in intact cells.
Verheijen I; Tourlousse D; Vanderheyden PM; Backer JP; Vauquelin G
Biochem Pharmacol; 2004 Apr; 67(8):1601-6. PubMed ID: 15041477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
